AAAAAA
Results: 1-25/47
Authors:
BEGG CB
CRAMER LD
HOSKINS WJ
BRENNAN MF
Citation: Cb. Begg et al., IMPACT OF HOSPITAL VOLUME ON OPERATIVE MORTALITY FOR MAJOR CANCER-SURGERY, JAMA, the journal of the American Medical Association, 280(20), 1998, pp. 1747-1751
Authors:
BOENTE MP
CHI DS
HOSKINS WJ
Citation: Mp. Boente et al., THE ROLE OF SURGERY IN THE MANAGEMENT OF OVARIAN-CANCER - PRIMARY ANDINTERVAL CYTOREDUCTIVE SURGERY, Seminars in oncology, 25(3), 1998, pp. 326-334
Authors:
FINSTAD CL
LLOYD KO
FEDERICI MG
DIVGI C
VENKATRAMAN E
BARAKAT RR
FINN RD
LARSON SM
HOSKINS WJ
HUMM JL
Citation: Cl. Finstad et al., DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY MX35 F(AB')2 IN TISSUE SAMPLES BY STORAGE PHOSPHOR SCREEN IMAGE-ANALYSIS - EVALUATION OF ANTIBODY LOCALIZATION TO MICROMETASTATIC DISEASE IN EPITHELIAL OVARIAN-CANCER, Clinical cancer research, 3(8), 1997, pp. 1433-1442
Authors:
HOSKINS WJ
MCGUIRE WP
BRADY MF
KUCERA PR
PARTRIDGE EE
LOOK KY
CLARKEPEARSON DL
DAVIDSON M
Citation: Wj. Hoskins et al., COMBINATION PACLITAXEL (TAXOL(R))-CISPLATIN VS CYCLOPHOSPHAMIDE-CISPLATIN AS PRIMARY THERAPY IN PATIENTS WITH SUBOPTIMALLY DEBULKED ADVANCED OVARIAN-CANCER, International journal of gynecological cancer, 7, 1997, pp. 9-13
Authors:
MCGUIRE WP
HOSKINS WJ
BRADY MF
KUCERA PR
PARTRIDGE EE
LOOK KY
CLARKPEARSON DL
DAVIDSON M
Citation: Wp. Mcguire et al., COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-IIIAND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Seminars in oncology, 24(1), 1997, pp. 13-16
Authors:
FENNELLY DW
AGHAJANIAN C
SHAPIRO F
OFLAHERTY C
OCONNOR K
CURTIN JP
CROWN JP
HOSKINS WJ
SPRIGGS DR
Citation: Dw. Fennelly et al., DOSE-ESCALATION OF PACLITAXEL WITH HIGH-DOSE CARBOPLATIN USING PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH ADVANCED OVARIAN-CANCER, Seminars in oncology, 24(1), 1997, pp. 26-30
Authors:
CURTIN JP
MALIK R
VENKATRAMAN ES
BARAKAT RR
HOSKINS WJ
Citation: Jp. Curtin et al., STAGE-IV OVARIAN-CANCER - IMPACT OF SURGICAL DEBULKING, Gynecologic oncology, 64(1), 1997, pp. 9-12
Authors:
HOSKINS WJ
Citation: Wj. Hoskins, IN-VITRO AND IN-VIVO STUDIES ON THE DEVELOPMENT OF THE ALPHA-EMITTINGRADIONUCLIDE BISMUTH-212 FOR INTRAPERITONEAL USE AGAINST MICROSCOPIC OVARIAN-CARCINOMA - DISCUSSION, American journal of obstetrics and gynecology, 176(4), 1997, pp. 840-841
Authors:
HOSKINS WJ
Citation: Wj. Hoskins, HISTOLOGIC-CHANGES IN THE OVARIES OF CANCER-PRONE WOMEN - AN INDICATION OF PREMALIGNANT CHANGE, Journal of the National Cancer Institute, 88(24), 1996, pp. 1790-1791
Authors:
MCGUIRE WP
HOSKINS WJ
BRADY MF
KUCERA PR
PARTRIDGE EE
LOOK KY
CLARKEPEARSON DL
DAVIDSON M
Citation: Wp. Mcguire et al., COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL TAXOL(R) AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-III AND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, International journal of gynecological cancer, 6, 1996, pp. 2-8
Authors:
ALBERTS DS
LIU PY
HANNIGAN EV
OTOOLE R
WILLIAMS SD
YOUNG JA
FRANKLIN EW
CLARKEPEARSON DL
MALVIYA VK
DUBESHTER B
HOSKINS WJ
ADELSON MD
ALVAREZ RD
OSULLIVAN J
GARCIA DJ
SPARKS DB
QUADE J
ROTHENBERG ML
Citation: Ds. Alberts et al., PHASE-III STUDY OF INTRAPERITONEAL CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE IN PATIENTS WITH OPTIMAL DISEASE STAGE-III OVARIAN-CANCER - A SWOG-GOG-ECOG INTERGROUP STUDY, International journal of gynecological cancer, 6, 1996, pp. 28-29
Authors:
RUSTIN GJS
NELSTROP AE
MCCLEAN P
BRADY MF
MCGUIRE WP
HOSKINS WJ
MITCHELL H
LAMBERT HE
Citation: Gjs. Rustin et al., DEFINING RESPONSE OF OVARIAN-CARCINOMA TO INITIAL CHEMOTHERAPY ACCORDING TO SERUM CA-125, Journal of clinical oncology, 14(5), 1996, pp. 1545-1551
Authors:
MCGUIRE WP
HOSKINS WJ
BRADY MF
KUCERA PR
PARTRIDGE EE
LOOK KY
CLARKEPEARSON DL
DAVIDSON M
Citation: Wp. Mcguire et al., CYCLOPHOSPHAMIDE AND CISPLATIN VERSUS PACLITAXEL AND CISPLATIN - A PHASE-III RANDOMIZED TRIAL IN PATIENTS WITH SUBOPTIMAL STAGE III IV OVARIAN-CANCER (FROM THE GYNECOLOGIC-ONCOLOGY-GROUP)/, Seminars in oncology, 23(5), 1996, pp. 40-47
Authors:
CURTIN JP
HOSKINS WJ
VENKATRAMAN ES
ALMADRONES L
PODRATZ KC
LONG H
TENERIELLO M
AVERETTE H
SEVIN BU
Citation: Jp. Curtin et al., ADJUVANT CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS PELVIC IRRADIATION FORHIGH-RISK CERVICAL-CANCER PATIENTS AFTER RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY (RH-PLND) - A RANDOMIZED PHASE-III TRIAL, Gynecologic oncology, 61(1), 1996, pp. 3-10
Authors:
GOGAS H
SHAPIRO F
AGHAJANIAN C
FENNELLY D
ALMADRONES L
HOSKINS WJ
SPRIGGS DR
Citation: H. Gogas et al., THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER, Gynecologic oncology, 61(1), 1996, pp. 22-26
Authors:
ABURUSTUM NR
BARAKAT RR
SIEGEL PL
VENKATRAMAN E
CURTIN JP
HOSKINS WJ
Citation: Nr. Aburustum et al., 2ND-LOOK OPERATION FOR EPITHELIAL OVARIAN-CANCER - LAPAROSCOPY OR LAPAROTOMY, Obstetrics and gynecology, 88(4), 1996, pp. 549-553
Authors:
STIER EA
BARAKAT RR
CURTIN JP
BROWN CL
JONES WB
HOSKINS WJ
Citation: Ea. Stier et al., LAPAROTOMY TO COMPLETE STAGING OF PRESUMED EARLY OVARIAN-CANCER, Obstetrics and gynecology, 87(5), 1996, pp. 737-740
Authors:
ALBERTS DS
LIU PY
HANNIGAN EV
OTOOLE R
WILLIAMS SD
YOUNG JA
FRANKLIN EW
CLARKEPEARSON DL
MALVIYA VK
DUBESHTER B
ADELSON MD
HOSKINS WJ
Citation: Ds. Alberts et al., INTRAPERITONEAL CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE FOR STAGE-III OVARIAN-CANCER, The New England journal of medicine, 335(26), 1996, pp. 1950-1955
Authors:
MCGUIRE WP
HOSKINS WJ
BRADY MF
Citation: Wp. Mcguire et al., CHEMOTHERAPY FOR OVARIAN-CANCER - REPLY, The New England journal of medicine, 334(19), 1996, pp. 1270-1270
Authors:
MCGUIRE WP
HOSKINS WJ
BRADY MF
KUCERA PR
PARTRIDGE EE
LOOK KY
CLARKEPEARSON DL
DAVIDSON M
Citation: Wp. Mcguire et al., CYCLOPHOSPHAMIDE AND CISPLATIN COMPARED WITH PACLITAXEL AND CISPLATININ PATIENTS WITH STAGE-III AND STAGE-IV OVARIAN-CANCER, The New England journal of medicine, 334(1), 1996, pp. 1-6
Authors:
YIN BWT
FINSTAD CL
KITAMURA K
FEDERICI MG
WELSHINGER M
KUDRYASHOV V
HOSKINS WJ
WELT S
LLOYD KO
Citation: Bwt. Yin et al., SEROLOGICAL AND IMMUNOCHEMICAL ANALYSIS OF LEWIS-Y (LE(Y)) BLOOD-GROUP ANTIGEN EXPRESSION IN EPITHELIAL OVARIAN-CANCER, International journal of cancer, 65(4), 1996, pp. 406-412
Authors:
ALBERTS DS
HEDDENS DK
GARCIA DJ
WILLIAMS SD
HANNIGAN EV
HOSKINS WJ
OTOOLE R
QUADE J
OSULLIVAN J
Citation: Ds. Alberts et al., CHEMOTHERAPY-INDUCED ANEMIA AND PACKED RED-BLOOD-CELL (PRBC) TRANSFUSIONS IN ADVANCED OVARIAN-CANCER PATIENTS ENROLLED IN A PHASE-III STUDYOF CISPLATIN PLUS CYCLOPHOSPHAMIDE, Blood, 88(10), 1996, pp. 2760-2760
Authors:
MCGUIRE WP
HOSKINS WJ
BRADY MF
HOMESLEY HD
CREASMAN WT
BERMAN ML
BALL H
BEREK JS
WOODWARD J
Citation: Wp. Mcguire et al., ASSESSMENT OF DOSE-INTENSIVE THERAPY IN SUBOPTIMALLY DEBULKED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(7), 1995, pp. 1589-1599
Authors:
HOSKINS WJ
Citation: Wj. Hoskins, PROSPECTIVE ON OVARIAN-CANCER - WHY PREVENT, Journal of cellular biochemistry, 1995, pp. 189-199
Authors:
THIGPEN T
VANCE RB
MCGUIRE WP
HOSKINS WJ
BRADY M
Citation: T. Thigpen et al., ROLE OF PACLITAXEL IN THE MANAGEMENT OF CELOMIC EPITHELIAL CARCINOMA OF THE OVARY - A REVIEW WITH EMPHASIS ON THE GYNECOLOGIC-ONCOLOGY-GROUP EXPERIENCE, Seminars in oncology, 22(6), 1995, pp. 23-31